Safe Bulkers, Inc. Enters Into a US $210.0 Million Reducing

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Safe Bulkers, Inc. Enters Into a US $210.0 Million Reducing Revolving Credit Facility Agreement With DNB Bank ASA

ATHENS, GREECE--(Marketwired - Sep 22, 2014) -  Safe Bulkers, Inc. (the "Company") (NYSE: SB), an international provider of marine drybulk transportation services, announced today that it has entered into a US $210.0 million, six-year, reducing revolving credit facility agreement with DNB Bank ASA, secured by ten vessels.

Under the agreement, the Company will be subject to the following financial covenants which will be measured on a consolidated basis:

  • The total consolidated liabilities of the Company divided by its total consolidated assets must not exceed 85%.
  • The ratio of the Company's EBITDA1 to its interest expense must be less than 2.0:1 on a trailing 12 month basis.
  • The consolidated net worth of the Company (total consolidated assets less total consolidated liabilities) must not be less than $150.0 million.

The new credit facility will be used to finance the acquisition of two previously contracted newbuild vessels, scheduled to be delivered to the Company in 2015, and to replace and prolong an existing credit facility with the same lender, presently secured by eight existing vessels.

The Company intends to finance its newbuild program with cash on hand and bank financing. With this reducing revolving credit facility and the other committed credit facilities, the Company has secured bank financing for twelve out of thirteen newbuild vessels on order.

About Safe Bulkers, Inc. The Company is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along worldwide shipping routes for some of the world's largest users of marine drybulk transportation services. The Company's common stock, series B and series C preferred stock is listed on the NYSE, where it trades under the symbols "SB", "SB.PR.B", "SB.PR.C" and "SB.PR.D", respectively. The Company's current fleet consists of 31 drybulk vessels, all built 2003 onwards, and the Company has agreed to acquire 13 additional drybulk newbuild vessels to be delivered at various times through 2017.

Forward-Looking Statements This press release contains forward-looking statements (as defined in Section 27A of the Securities Exchange Act of 1933, as amended, and in the Section 21E of the Securities Act of 1934, as amended) concerning future events, the Company's growth strategy and measures to implement such strategy, including expected vessel acquisitions and entering into further time charters. Words such as "expects," "intends," "plans," "believes," "anticipates," "hopes," "estimates" and variations of such words and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates which are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, changes in the demand for drybulk vessels, competitive factors in the market in which the Company operates, risks associated with operations outside the United States and other factors listed from time to time in the Company's filings with the Securities and Exchange Commission. The Company expressly disclaims any obligations or undertaking to release any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

1 EBITDA is not a recognized measurement under US GAAP and represents net income before net interest expense, income tax expense, depreciation and amortization.

For further information please contact: Company Contact: Dr. Loukas Barmparis President Safe Bulkers, Inc. Athens, Greece Tel.: +30 2 111 888 400 Fax: +30 2 111 878 500 E-Mail: directors@safebulkers.com Investor Relations / Media Contact: Nicolas Bornozis President Capital Link, Inc. 230 Park Avenue, Suite 1536 New York, N.Y. 10169 Tel.: (212) 661-7566 Fax: (212) 661-7526 E-Mail: safebulkers@capitallink.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fort Riley and Fort Wainwright Get Wi-Fi Boost

Updated Category News Views 11

Reliable Connectivity for Soldiers: A Strategic Move Wi-Fi probably wouldn't be on top of the list in a battlefield strategy session, but give it a thought—it’s the digital lifeline for our troops off-duty. That’s what’s cooking with the U.S. Army’s big move to amp up reliable Wi-Fi at Fort Riley and Fort Wainwright, thanks to Boldyn Networks and their BaseNet...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 240

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Leatt Gears Up for Q3 Results Conference Call

Updated Category News Views 83

A good heads-up, folks, isn't just about keeping helmets snug—it’s about knowing when to cash in, especially when Leatt Corporation's got their Q3 results ready to drop. November 12 is the big day, so circle that on your calendars. They're rolling out the numbers before the market even gets its coffee, possibly nudging the ticker, OTCQB:LEAT, in a ripple you’ll want...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 172

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 671

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Wendy C. Wilson Earns Inner Circle Pinnacle Honor

Updated Category News Views 20

Leadership Recognized: Wendy C. Wilson's Impact Some folks know their way around the trenches of corporate battle, and Wendy C. Wilson is one of them. Known for her grit and savvy, she now takes a coveted spot in The Inner Circle of Excellence as a Pinnacle Professional Member. This title isn't just for show—it's a hat tip to her powerhouse contributions as a speaker on...

Continue Reading
Spatial Genomics Market Set for Major Expansion by 2031

Updated Category News Views 23

The Rise of Spatial Genomics You’ve got to hand it to the science behind spatial genomics and transcriptomics—this arena’s not just on a hot streak; it’s scorching. We’re staring down the barrel of a market raring to more than double in value, surging from a worth of USD 0.67 billion in 2026 straight to the big USD 1.23 billion in 2031. The CAGR that’s...

Continue Reading
PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

Updated Category News Views 99

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Continue Reading
Alscan Clinches Three PSA Awards, Sets Industry Standard

Updated Category News Views 46

Alscan's Triple Trophy Triumph with PSA Network in 2026 Talk about setting the bar high! Alscan snagged not one, not two, but three prestigious awards from the PSA Network—quite a haul for any outfit looking to make waves in the security systems game. The recognition showcases their prowess in custom security solutions, serving businesses and industries with vigilance...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 194

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Upgrades for Top Stocks: Analysts Favor Henry Schein

Updated Category News Views 143

Top Analyst Upgrades for Leading Stocks In the dynamic world of investing, analyst ratings can significantly influence stock performance. Recently, top Wall Street analysts have revised their outlooks on several prominent companies, providing fresh insights for investors. Here’s a look at the latest upgrades and what they could mean for these stocks. Okta Receives a...

Continue Reading
Multiple Sclerosis Diagnosis and Treatment Market Insights

Updated Category News Views 112

Overview of the Multiple Sclerosis Diagnosis and Treatment Market The global market for multiple sclerosis (MS) diagnosis and treatment is experiencing steady growth, currently valued at around USD 22.14 billion. Forecasts suggest that this figure could rise to USD 30.28 billion by 2032. This growth is largely driven by the increasing number of MS cases and advancements...

Continue Reading
Checkbook Teams Up with J.P. Morgan to Transform Payments

Updated Category News Views 200

Checkbook Partners with J.P. Morgan Payments Network San Mateo, CA - Checkbook, an innovator in digital payments, announced its membership in the J.P. Morgan Payments Partner Network. This collaboration aims to transform the realm of digital check payments, making it easier for corporate clients of J.P. Morgan Payments to send digital checks directly from their bank...

Continue Reading
Lemonade Exceeds Expectations: Earnings and Revenue Insights

Updated Category News Views 154

Lemonade's Impressive Earnings Performance Lemonade (NYSE: LMND) recently delivered its third quarter earnings, posting an EPS of $-0.95, which is $0.07 better than analysts' expectations of $-1.02. This performance highlights the company's resilience and ability to navigate market challenges effectively. Despite operating in a competitive landscape, Lemonade's innovative...

Continue Reading
Understanding the Rise in GigaCloud Tech's Short Interest

Updated Category News Views 102

Examining the Increase in GigaCloud Tech's Short Interest GigaCloud Tech has seen a significant rise in its short percent of float, increasing by 3.8% since the last report. Currently, the company indicates that 5.85 million shares have been sold short, which accounts for 31.11% of all regular shares available for trading. This implies that traders may need an average of...

Continue Reading